These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20155829)

  • 41. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
    J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.
    Murray SG; Yazdany J; Kaiser R; Criswell LA; Trupin L; Yelin EH; Katz PP; Julian LJ
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1328-33. PubMed ID: 22549897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychological assessment of cognitive disorders in patients with fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus.
    de Melo LF; Da-Silva SL
    Rev Bras Reumatol; 2012; 52(2):181-8. PubMed ID: 22460408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of cognitive performance in systemic lupus erythematosus.
    Breitbach SA; Alexander RW; Daltroy LH; Liang MH; Boll TJ; Karlson EW; Partiridge AJ; Roberts WN; Stern SH; Wacholtz MC; Straaton KV
    J Clin Exp Neuropsychol; 1998 Apr; 20(2):157-66. PubMed ID: 9777469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.
    Wojcik CM; Rao SM; Schembri AJ; Drake AS; Maruff P; Schindler D; Alberts J; Yasin F; Pol J; Weinstock-Guttman B; Benedict RH
    Mult Scler; 2020 Jan; 26(1):109-113. PubMed ID: 30465463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus.
    Ross GS; Zelko F; Klein-Gitelman M; Levy DM; Muscal E; Schanberg LE; Anthony K; Brunner HI;
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1029-33. PubMed ID: 20589693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved executive function in patients with systemic lupus erythematosus following interactive digital training.
    Kozora E; Zell JL; Baraghoshi D; Smith RM; Strand M
    Lupus; 2022 Jul; 31(8):910-920. PubMed ID: 35584197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.
    Benedict RH; Shucard JL; Zivadinov R; Shucard DW
    Neuropsychol Rev; 2008 Jun; 18(2):149-66. PubMed ID: 18521755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between perceived cognitive dysfunction and objective neuropsychological performance in persons with rheumatoid arthritis.
    Shin SY; Katz P; Julian L
    Arthritis Care Res (Hoboken); 2013 Mar; 65(3):481-6. PubMed ID: 22899659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
    Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
    Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
    Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of common susceptibility genes and drug target genes in multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis and its value to guide clinical treatment.
    Liu Y; Rang X; Zou X; Wang X; Zhang X; Wang Y; Xu C; Fu J
    Mult Scler Relat Disord; 2022 Feb; 58():103504. PubMed ID: 35030369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurocognitive impairment in corticosteroid-naive patients with active systemic lupus erythematosus: a prospective study.
    Nishimura K; Omori M; Katsumata Y; Sato E; Gono T; Kawaguchi Y; Harigai M; Mimura M; Yamanaka H; Ishigooka J
    J Rheumatol; 2015 Mar; 42(3):441-8. PubMed ID: 25593228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychological patterns in systemic lupus erythematosus patients with depression.
    Kozora E; Arciniegas DB; Zhang L; West S
    Arthritis Res Ther; 2007; 9(3):R48. PubMed ID: 17504538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Divergent perceptions in health-related quality of life between family members and patients with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis.
    Ramos-Remus C; Castillo-Ortiz JD; Sandoval-Castro C; Paez-Agraz F; Sanchez-Ortiz A; Aceves-Avila FJ
    Rheumatol Int; 2014 Dec; 34(12):1743-9. PubMed ID: 24859395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive deficit in patients with systemic lupus erythematosus.
    Maneeton B; Maneeton N; Louthrenoo W
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):77-83. PubMed ID: 20527520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus.
    Glanz BI; Slonim D; Urowitz MB; Gladman DD; Gough J; MacKinnon A
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):232-8. PubMed ID: 9359119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliable screening for neuropsychological impairment in multiple sclerosis.
    Benedict RH; Cox D; Thompson LL; Foley F; Weinstock-Guttman B; Munschauer F
    Mult Scler; 2004 Dec; 10(6):675-8. PubMed ID: 15584493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.